CN117562840A - 一种可以预防口腔溃疡的洁牙慕斯 - Google Patents
一种可以预防口腔溃疡的洁牙慕斯 Download PDFInfo
- Publication number
- CN117562840A CN117562840A CN202311522023.4A CN202311522023A CN117562840A CN 117562840 A CN117562840 A CN 117562840A CN 202311522023 A CN202311522023 A CN 202311522023A CN 117562840 A CN117562840 A CN 117562840A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- phase
- dental
- mousse
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000195940 Bryophyta Species 0.000 title claims abstract description 43
- 235000011929 mousse Nutrition 0.000 title claims abstract description 43
- 208000025865 Ulcer Diseases 0.000 title claims abstract description 37
- 231100000397 ulcer Toxicity 0.000 title claims abstract description 36
- 238000004140 cleaning Methods 0.000 title claims abstract description 28
- 239000000284 extract Substances 0.000 claims abstract description 105
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 26
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 21
- 229940069445 licorice extract Drugs 0.000 claims abstract description 20
- 235000016623 Fragaria vesca Nutrition 0.000 claims abstract description 17
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims abstract description 17
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 16
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 16
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 14
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 14
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 108700004121 sarkosyl Proteins 0.000 claims abstract description 14
- 229940045944 sodium lauroyl glutamate Drugs 0.000 claims abstract description 14
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims abstract description 14
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 claims abstract description 14
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 claims abstract description 14
- 239000000600 sorbitol Substances 0.000 claims abstract description 14
- 239000000811 xylitol Substances 0.000 claims abstract description 14
- 235000010447 xylitol Nutrition 0.000 claims abstract description 14
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 14
- 229960002675 xylitol Drugs 0.000 claims abstract description 14
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 13
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 13
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 13
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims abstract description 11
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 8
- 229960000458 allantoin Drugs 0.000 claims abstract description 8
- 208000002925 dental caries Diseases 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 25
- 238000002360 preparation method Methods 0.000 claims description 23
- 241000220223 Fragaria Species 0.000 claims description 16
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 13
- 229960004998 acesulfame potassium Drugs 0.000 claims description 13
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 13
- 239000000619 acesulfame-K Substances 0.000 claims description 13
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 13
- 239000004299 sodium benzoate Substances 0.000 claims description 13
- 235000010234 sodium benzoate Nutrition 0.000 claims description 13
- 244000046146 Pueraria lobata Species 0.000 claims description 12
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 208000020670 canker sore Diseases 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000001694 spray drying Methods 0.000 claims description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 238000007599 discharging Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 229960002920 sorbitol Drugs 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000000606 toothpaste Substances 0.000 abstract description 13
- 229940034610 toothpaste Drugs 0.000 abstract description 12
- 239000003814 drug Substances 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 9
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 230000004054 inflammatory process Effects 0.000 abstract description 6
- 241000700605 Viruses Species 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 241000894006 Bacteria Species 0.000 abstract description 4
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 4
- 208000026935 allergic disease Diseases 0.000 abstract description 4
- 230000007815 allergy Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 210000001124 body fluid Anatomy 0.000 abstract description 3
- 239000010839 body fluid Substances 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 238000010791 quenching Methods 0.000 abstract description 3
- 230000035922 thirst Effects 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 240000009088 Fragaria x ananassa Species 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 description 8
- 208000002399 aphthous stomatitis Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 5
- 208000007117 Oral Ulcer Diseases 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000011362 coarse particle Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- TURHTASYUMWZCC-UHFFFAOYSA-N Olaquindox [BAN:INN] Chemical compound C1=CC=C2N([O-])C(C)=C(C(=O)NCCO)[N+](=O)C2=C1 TURHTASYUMWZCC-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000219780 Pueraria Species 0.000 description 2
- -1 coumarin, amino acid Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 229950010210 olaquindox Drugs 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000020061 Hand, Foot and Mouth Disease Diseases 0.000 description 1
- 208000025713 Hand-foot-and-mouth disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- 229940051810 licorice root extract Drugs 0.000 description 1
- 235000020725 licorice root extract Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 208000018555 lymphatic system disease Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000001720 vestibular Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Cosmetics (AREA)
Abstract
本发明提供一种可以预防口腔溃疡的洁牙慕斯,涉及牙膏的技术领域,包括以下组分,以重量份计:山梨醇5‑10份;木糖醇3‑8份;月桂酰谷氨酸钠3‑8份;月桂酰肌氨酸钠1‑5份;尿囊素0.1‑1.5份;甜叶菊提取物0.1‑1.2份:忍冬花提取物0.1‑1份;甘草提取物0.1‑1份;葛根提取物0.1‑1份;草莓提取物0.1‑1份;奥拉氟0.01‑0.11份;抗坏血酸0.1‑1份;水70~75份,本发明所提供的洁牙慕斯采用多组中药提取物,相互配伍协同增效,具有清热解毒、生津止渴、抗菌、抗炎、抗病毒,且能够增强免疫力和抗过敏功效,与奥拉氟等多种成分复配形成更能适用于儿童的洁牙慕斯,从而起到预防口腔溃疡和牙齿龋坏的作用。
Description
技术领域
本发明涉及牙膏的技术领域,具体而言,涉及一种可以预防口腔溃疡的洁牙慕斯。
背景技术
口腔是一个温暖、湿润、直接与外界相通的不规则腔隙,口腔的温度、湿度及食物残渣适宜微生物的生长繁殖。当机体处于疾病状态时,机体防御功能下降,并可能伴有因进食或饮水障碍等造成的自我口腔清洁下降,导致口腔内致病菌大量繁殖,引起口腔卫生不洁,甚至出现口腔局部炎症和溃疡等口腔疾病。
口腔溃疡俗称“口疮”,是一种常见的发生于口腔黏膜的溃疡性损伤病症,多见于唇内侧、舌头、舌腹、颊黏膜、前庭沟、软聘等部位,这些部位的黏膜缺乏角质化层或角化较差。
儿童在成长过程中也极其容易患上口腔溃疡,主要有以下几个造成,比如创伤、缺乏维生素、或者手足口病等,口腔溃疡在发作时疼痛剧烈,局部灼痛明显,严重者还会影响儿童饮食、说话,对日常生活造成极大不便,还可并发口臭、慢性咽炎、便秘、头痛、头晕、恶心、乏力、烦躁、发热、淋巴结肿大等全身症状,因此有必要提供一种能够预防口腔溃疡的洁牙慕斯。
发明内容
本发明的目的在于提供一种可以预防口腔溃疡的洁牙慕斯,包括以下组分,以重量份计:
山梨醇5-10份;木糖醇3-8份;月桂酰谷氨酸钠3-8份;
月桂酰肌氨酸钠1-5份;尿囊素0.1-1.5份;甜叶菊提取物0.1-1.2份:
忍冬花提取物0.1-1份;甘草提取物0.1-1份;葛根提取物0.1-1份;
草莓提取物0.1-1份;奥拉氟0.01-0.11份;抗坏血酸0.1-1份;
水70~75份。
本发明通过采用在洁牙慕斯中添加甜叶菊提取物、葛根提取物、忍冬花提取物和甘草提取物,在长期使用过程中,能够起到抗炎灭菌、抗病毒、抗过敏、增强免疫和预防口腔溃疡的作用,维持口腔健康,另外还含有奥拉氟,在制备过程中该奥拉氟添加为总共含量的0.11%,符合国家添加比例中的最高标准,能够对防止儿童龋坏起到更好的预防效果,还添加草莓提取物,提高儿童的接受度,其中涉及到的山梨醇和木糖醇为保湿剂,月桂酰谷氨酸钠和月桂酰肌氨酸钠为发泡剂。
为了更好的实现本发明,进一步的,包括以下组分,以重量份计:
山梨醇8份;木糖醇5份;月桂酰谷氨酸钠5份;
月桂酰肌氨酸钠3份;尿囊素1份;甜叶菊提取物0.8份:
忍冬花提取物0.5份;甘草提取物0.5份;葛根提取物0.5份;
草莓提取物0.5份;奥拉氟0.11份;抗坏血酸0.5份;
水73.2份。
为了更好的实现本发明,进一步的,还包括以下组分,以重量份计:
安赛蜜0.01-0.15份;苯甲酸钠0.1-1份,食用香精0.5-1.5份。
在制备过程该安赛蜜起到甜味剂,增强儿童的接受度,苯甲酸钠为防腐剂,食用香精为口感改良剂,使其加强洁牙慕斯的口感。
为了更好的实现本发明,进一步的,还包括以下组分,以重量份计:
安赛蜜0.1份;苯甲酸钠0.5份,食用香精0.8份。
一种可以预防口腔溃疡的洁牙慕斯制备方法,包括以下步骤:
设置有A相、B相、C相和D相;
所述A相为月桂酰谷氨酸钠、月桂酰肌氨酸钠、木糖醇、山梨醇和水;
所述B相为甜叶菊提取物、忍冬花提取物、甘草提取物、葛根提取物、草莓提取物和水;
所述C相为奥拉氟和抗坏血酸;
所述D相为安赛蜜、苯甲酸钠和食用香精;
首先将A相加入在搅拌锅中,搅拌加热至80-85℃,完全溶解;
然后将B相继续加热搅拌,并逐渐降温至55℃,搅拌至完全透明形;
再将C相和D相同时加入,并继续搅拌,出料、过滤得到成品。
本发明所提供的准备方法,能够使有益成分均匀的分散在产品中,且有效发挥抗菌、抗炎、抗病毒和提高免疫力,预防口腔溃疡的效果,该制作方法操作简单,原料易得,且成本低。
为了更好的实现本发明,进一步的,所述葛根提取物的制备工艺:
取葛根饮片,洗净并破碎成粗粒,加水煎煮提取2次,第一次煎煮的时间为2-4h,第二煎煮时间为0.5-1.5h,合并两次滤液并静置、过滤,得到葛根提取液;
将葛根提取液放置在真空度为0.06~0.08Mpa进行浓缩,得到相对密度为1.10-1.15,温度为70-80℃的浓缩稠浸物,将浓缩稠浸物进行喷雾干燥,干燥后将其粉碎,得到葛根提取物。
为了更好的实现本发明,进一步的,所述喷雾干燥的条件是入口温度175-185℃,出口温度65-75℃。
为了更好的实现本发明,进一步的,
忍冬花提取物的制作工艺:
挑选优良品质的忍冬花,加入水和溶剂进行蒸馏,得到忍冬花提取物。
为了更好的实现本发明,进一步的,甘草提取物的制作工艺:
选用甘草的根和茎,加水进行浸提后得到甘草浸膏,加入乙醇并置于微波中,其中甘草浸膏与乙醇的固液比为1:6-10,乙醇浓度为85%,微波低火处理1-5min。
草莓提取物的制备工艺:
挑选优质草莓,将其清洗干净,将其切成薄片,进行烘干,然后研磨成粉,将粉末状的草莓加入水、乙酸乙酯进行混合得到混合液,在进行蒸馏浓缩,得到草莓提取物。
本发明的有益效果是:
本发明所提供的预防口腔溃疡的洁牙慕斯,其有效成分是甜叶菊提取物、忍冬花提取物、甘草提取物和葛根提取物,该甜叶菊提取物含有甜叶糖苷、叶酸、甜菜碱、叶黄素等成分,具有清热解毒、咽喉肿痛等作用,忍冬花提取物其主要成分为绿原酸和异绿原酸为主,具有抗菌、抗病毒、解热、抗炎、增强免疫、抗肿瘤、抗过敏、保肝、利胆、降血糖等作用,甘草提取物主要成分为三萜类和黄酮类还含有生物碱、多糖、香豆素、氨基酸及Zn、Ca、Sr、Ni、Mn、Fe、Cu、Cr等,具有补脾益气、润肺止咳、清热解毒和调和诸药等功效外,还用于咽喉肿痛、脾胃虚寒、消化性溃疡、中毒等症状。葛根含有葛根素、黄酮类化合物,能够解肌退热,透疹,生津止渴,升阳止泻,通经活络,解酒毒之功,另外还含有奥拉氟,有利于防止儿童龋坏,提供对儿童牙齿和口腔更健康的洁牙慕斯,将上述甜叶菊提取物、忍冬花提取物、甘草提取物和葛根提取物这些中药组合物进行复配,协同用于儿童口腔中,能够对儿童口腔进行消炎抗菌,优化儿童口腔环境,减轻口腔病态症状,达到预防口腔溃疡的发生。
本发明所提供的洁牙慕斯采用多组中药提取物,相互配伍协同增效,具有清热解毒、生津止渴、抗菌、抗炎、抗病毒,且能够增强免疫力和抗过敏功效,与奥拉氟等多种成分复配形成更能适用于儿童的洁牙慕斯,从而起到预防口腔溃疡和牙齿龋坏的作用,该制备方法简单,操作简易。
具体实施方式
下面将结合本发明中的实施例,对本发明中的技术方案进行描述。
实施例1
本发明提供一种可以预防口腔溃疡的洁牙慕斯,包括以下组分,以重量份计:山梨醇5份;木糖醇3份;月桂酰谷氨酸钠3份;月桂酰肌氨酸钠1份;尿囊素0.1份;甜叶菊提取物0.1份:忍冬花提取物0.1份;甘草提取物0.1份;葛根提取物0.1份;草莓提取物0.1份;奥拉氟0.01份;抗坏血酸0.1份;水70份;安赛蜜0.01份;苯甲酸钠0.1份,食用香精0.5份。
制备方法:
包括以下步骤:
设置有A相、B相、C相和D相;
所述A相为月桂酰谷氨酸钠、月桂酰肌氨酸钠、木糖醇、山梨醇和水;
所述B相为甜叶菊提取物、忍冬花提取物、甘草提取物、葛根提取物、草莓提取物和水;
所述C相为奥拉氟和抗坏血酸;
所述D相为安赛蜜、苯甲酸钠和食用香精;
首先将A相加入在搅拌锅中,搅拌加热至80℃,完全溶解;
然后将B相继续加热搅拌,并逐渐降温至55℃,搅拌至完全透明形;
再将C相和D相同时加入,并继续搅拌,出料、过滤得到成品。
所述葛根提取物的制备工艺:
取葛根饮片,洗净并破碎成粗粒,加水煎煮提取2次,第一次煎煮的时间为3h,第二煎煮时间为1h,合并两次滤液并静置、过滤,得到葛根提取液;
将葛根提取液放置在真空度为0.06~0.08Mpa进行浓缩,得到相对密度为1.10-1.15,温度为70-80℃的浓缩稠浸物,将浓缩稠浸物进行喷雾干燥,所述喷雾干燥的条件是入口温度175-185℃,出口温度65-75℃,干燥后将其粉碎,得到葛根提取物。
忍冬花提取物的制作工艺:
挑选优良品质的忍冬花,加入水和溶剂进行蒸馏,得到忍冬花提取物。
甘草提取物的制作工艺:
选用甘草的根和茎,加水进行浸提后得到甘草浸膏,加入乙醇并置于微波中,其中甘草浸膏与乙醇的固液比为1:6-10,乙醇浓度为85%,微波低火处理3min。
实施例2
本发明提供一种可以预防口腔溃疡的洁牙慕斯,包括以下组分,以重量份计:山梨醇10份;木糖醇8份;月桂酰谷氨酸钠8份;月桂酰肌氨酸钠5份;尿囊素1.5份;甜叶菊提取物1.2份:忍冬花提取物1份;甘草提取物1份;葛根提取物1份;草莓提取物1份;奥拉氟0.11份;抗坏血酸1份;水75份;安赛蜜0.15份;苯甲酸钠1份,食用香精1.5份。
制备方法:
包括以下步骤:
设置有A相、B相、C相和D相;
所述A相为月桂酰谷氨酸钠、月桂酰肌氨酸钠、木糖醇、山梨醇和水;
所述B相为甜叶菊提取物、忍冬花提取物、甘草提取物、葛根提取物、草莓提取物和水;
所述C相为奥拉氟和抗坏血酸;
所述D相为安赛蜜、苯甲酸钠和食用香精;
首先将A相加入在搅拌锅中,搅拌加热至80-85℃,完全溶解;
然后将B相继续加热搅拌,并逐渐降温至55℃,搅拌至完全透明形;
再将C相和D相同时加入,并继续搅拌,出料、过滤得到成品。
所述葛根提取物的制备工艺:
取葛根饮片,洗净并破碎成粗粒,加水煎煮提取2次,第一次煎煮的时间为3h,第二煎煮时间为1h,合并两次滤液并静置、过滤,得到葛根提取液;
将葛根提取液放置在真空度为0.06~0.08Mpa进行浓缩,得到相对密度为1.10-1.15,温度为70-80℃的浓缩稠浸物,将浓缩稠浸物进行喷雾干燥,所述喷雾干燥的条件是入口温度175-185℃,出口温度65-75℃,干燥后将其粉碎,得到葛根提取物。
忍冬花提取物的制作工艺:
挑选优良品质的忍冬花,加入水和溶剂进行蒸馏,得到忍冬花提取物。
甘草提取物的制作工艺:
选用甘草的根和茎,加水进行浸提后得到甘草浸膏,加入乙醇并置于微波中,其中甘草浸膏与乙醇的固液比为1:6-10,乙醇浓度为85%,微波低火处理3min。
实施例3
本发明提供一种可以预防口腔溃疡的洁牙慕斯,包括以下组分,以重量份计:山梨醇8份;木糖醇5份;月桂酰谷氨酸钠5份;月桂酰肌氨酸钠3份;尿囊素1份;甜叶菊提取物0.8份:忍冬花提取物0.5份;甘草提取物0.5份;葛根提取物0.5份;草莓提取物0.5份;奥拉氟0.11份;抗坏血酸0.5份;水73.2份;安赛蜜0.1份;苯甲酸钠0.5份,食用香精0.8份。
制备方法:
包括以下步骤:
设置有A相、B相、C相和D相;
所述A相为月桂酰谷氨酸钠、月桂酰肌氨酸钠、木糖醇、山梨醇和水;
所述B相为甜叶菊提取物、忍冬花提取物、甘草提取物、葛根提取物、草莓提取物和水;
所述C相为奥拉氟和抗坏血酸;
所述D相为安赛蜜、苯甲酸钠和食用香精;
首先将A相加入在搅拌锅中,搅拌加热至80-85℃,完全溶解;
然后将B相继续加热搅拌,并逐渐降温至55℃,搅拌至完全透明形;
再将C相和D相同时加入,并继续搅拌,出料、过滤得到成品。
所述葛根提取物的制备工艺:
取葛根饮片,洗净并破碎成粗粒,加水煎煮提取2次,第一次煎煮的时间为3h,第二煎煮时间为1h,合并两次滤液并静置、过滤,得到葛根提取液;
将葛根提取液放置在真空度为0.06~0.08Mpa进行浓缩,得到相对密度为1.10-1.15,温度为70-80℃的浓缩稠浸物,将浓缩稠浸物进行喷雾干燥,所述喷雾干燥的条件是入口温度175-185℃,出口温度65-75℃,干燥后将其粉碎,得到葛根提取物。
忍冬花提取物的制作工艺:
挑选优良品质的忍冬花,加入水和溶剂进行蒸馏,得到忍冬花提取物。
甘草提取物的制作工艺:
选用甘草的根和茎,加水进行浸提后得到甘草浸膏,加入乙醇并置于微波中,其中甘草浸膏与乙醇的固液比为1:6-10,乙醇浓度为85%,微波低火处理1-5min。
实验例1:
收集了6家医疗机构6000名学龄前儿童,随机平均分成两组,一组为对照组,使用市场上儿童牙膏:另一组为使用了本发明实施例3制备出的洁牙慕斯。
两组人群均是每天早晚刷牙两次,坚持使用180天,然后依次检查使用者牙的口腔溃疡发病的情况,并记录下来。
疗效判定:采用分时段统计未患口腔溃疡人数
治疗:结果见表
从上述实验结果可以得出,本发明洁牙慕斯对口腔溃发生率为1.30%,而使用其它牙膏口腔溃疡发病率为19.06%,由此可知,未使用本发明洁牙慕斯(对照室组)的发病率是使用本发明的洁牙慕斯(实验室组)发病率的14.66倍,由此可见,本发明牙膏具有显著预防的效果。
实验例2
病例1:刘某,男,4岁,患有严重的口腔溃疡疾病,并长期伴有便秘和口干唇干的现象,一直没有得到正规和有效的药物治疗。曾四处求医用药,补充各种维生素,但总是反复发作口腔溃疡。经确诊是由心火旺盛引起的口腔溃疡,该儿童使用发明慕斯牙膏1个月后,口腔溃疡有出现但症状比以前轻很多,继续使用该发明慕斯牙膏5个月,后均未出现口腔溃疡复发情况。
病例2:陈某,男,3岁6个月,患有严重的口腔溃疡疾病,并长期伴有便秘的现象,一直没有得到正规和有效的药物治疗。曾四处求医用药,补充各种维生素、各种微力量元素、看中医吃中药,任然反复发作口腔溃疡。经确诊是由心火旺盛引起的口腔溃疡,该儿童使用本发明慕斯儿童牙膏1个月后,口腔溃疡有出现但症状比以前轻很多,继续使用该发明慕斯牙膏5个月,后均未出现口腔溃疡复发情况。
病例3:卢某,男,5岁6个月,患有严重的口腔溃疡疾病,并长期伴有口干的现象,一直没有得到正规和有效的药物治疗。曾四处求医用药,补充各种维生素、各种微力量元素,任然反复发作口腔溃疡。经确诊是由心火旺盛引起的口腔溃疡,该儿童使用本发明慕斯儿童牙膏1个月后,口腔溃疡有出现但症状比以前轻很多,口腔溃疡愈合期5天,大大缩短了愈合期;使用本发明慕斯儿童牙膏3个月后再次出现轻微口腔溃疡,3天后口腔溃疡愈合;继续使用该发明慕斯牙膏2个月,后均未出现口腔溃疡复发情况.
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应所述以权利要求的保护范围为准。
Claims (10)
1.一种可以预防口腔溃疡的洁牙慕斯,其特征在于,
包括以下组分,以重量份计:
山梨醇5-10份;木糖醇3-8份;月桂酰谷氨酸钠3-8份;
月桂酰肌氨酸钠1-5份;尿囊素0.1-1.5份;甜叶菊提取物0.1-1.2份:
忍冬花提取物0.1-1份;甘草提取物0.1-1份;葛根提取物0.1-1份;
草莓提取物0.1-1份;奥拉氟0.01-0.11份;抗坏血酸0.1-1份;
水70~75份。
2.根据权利要求1所述的可以预防口腔溃疡的洁牙慕斯,其特征在于,
包括以下组分,以重量份计:
山梨醇8份;木糖醇5份;月桂酰谷氨酸钠5份;
月桂酰肌氨酸钠3份;尿囊素1份;甜叶菊提取物0.8份:
忍冬花提取物0.5份;甘草提取物0.5份;葛根提取物0.5份;
草莓提取物0.5份;奥拉氟0.11份;抗坏血酸0.5份;
水73.2份。
3.根据权利要求1所述的可以预防口腔溃疡的洁牙慕斯,其特征在于,
还包括以下组分,以重量份计:
安赛蜜0.01-0.15份;苯甲酸钠0.1-1份,食用香精0.5-1.5份。
4.根据权利要求3所述的可以预防口腔溃疡的洁牙慕斯,其特征在于,
还包括以下组分,以重量份计:
安赛蜜0.1份;苯甲酸钠0.5份,食用香精0.8份。
5.根据权利要求3所述的可以预防口腔溃疡的洁牙慕斯的制备方法,其特征在于,包括以下步骤:
设置有A相、B相、C相和D相;
所述A相为月桂酰谷氨酸钠、月桂酰肌氨酸钠、木糖醇、山梨醇和水;
所述B相为甜叶菊提取物、忍冬花提取物、甘草提取物、葛根提取物、草莓提取物和水;
所述C相为奥拉氟和抗坏血酸;
所述D相为安赛蜜、苯甲酸钠和食用香精;
首先将A相加入在搅拌锅中,搅拌加热至80-85℃,完全溶解;
然后将B相继续加热搅拌,并逐渐降温至55℃,搅拌至完全透明形态;
再将C相和D相同时加入,并继续搅拌,出料、过滤得到成品。
6.根据权利要求5所述的可以预防口腔溃疡的洁牙慕斯的制备方法,其特征在于,所述葛根提取物的制备工艺:
取葛根饮片,洗净并破碎成粗粒,加水煎煮提取2次,第一次煎煮的时间为2-4h,第二煎煮时间为0.5-1.5h,合并两次滤液并静置、过滤,得到葛根提取液;
将葛根提取液放置在真空度为0.06~0.08Mpa进行浓缩,得到相对密度为1.10-1.15,温度为70-80℃的浓缩稠浸物,将浓缩稠浸物进行喷雾干燥,干燥后将其粉碎,得到葛根提取物。
7.根据权利要求6所述的可以预防口腔溃疡的洁牙慕斯的制备方法,其特征在于,所述喷雾干燥的条件是入口温度175-185℃,出口温度65-75℃。
8.根据权利要求5所述的可以预防口腔溃疡的洁牙慕斯的制备方法,其特征在于,忍冬花提取物的制作工艺:
挑选优良品质的忍冬花,加入水和溶剂进行蒸馏,得到忍冬花提取物。
9.根据权利要求5所述的可以预防口腔溃疡的洁牙慕斯的制备方法,其特征在于,甘草提取物的制作工艺:
选用甘草的根和茎,加水进行浸提后得到甘草浸膏,加入乙醇并置于微波中,其中甘草浸膏与乙醇的固液比为1:6-10,乙醇浓度为85%,微波低火处理1-5min。
10.一种可以预防口腔溃疡的洁牙慕斯,其特征在于,由权利要求5-9所述的制备方法制得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311522023.4A CN117562840A (zh) | 2023-11-15 | 2023-11-15 | 一种可以预防口腔溃疡的洁牙慕斯 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311522023.4A CN117562840A (zh) | 2023-11-15 | 2023-11-15 | 一种可以预防口腔溃疡的洁牙慕斯 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117562840A true CN117562840A (zh) | 2024-02-20 |
Family
ID=89863714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311522023.4A Pending CN117562840A (zh) | 2023-11-15 | 2023-11-15 | 一种可以预防口腔溃疡的洁牙慕斯 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117562840A (zh) |
-
2023
- 2023-11-15 CN CN202311522023.4A patent/CN117562840A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102198065A (zh) | 一种口腔喷雾剂及其制备方法 | |
WO2018021886A1 (ko) | 혼합 생약제 추출물을 유효성분으로 포함하는 숙취해소, 피로회복 및 면역력 증강용 식품 조성물 | |
CN105410346A (zh) | 提高养殖对虾存活率的中药制剂及其制备方法 | |
CN110946804B (zh) | 一种预防龋齿和口腔溃疡的漱口水及其制备方法 | |
CN110585302A (zh) | 一种治疗慢性咽炎的中药组合颗粒茶及其制备方法 | |
CN101342312B (zh) | 一种治疗咽炎的药物及其制备方法 | |
CN104027440B (zh) | 止咳化痰含片及其制备方法 | |
CN107823293B (zh) | 治疗口腔溃疡的瑶医外用散剂及其制备方法 | |
CN1907374A (zh) | 一种防治口腔疾病的中药组合物 | |
CN102772777B (zh) | 一种治疗小儿肺炎的药物及其制备方法 | |
CN117562840A (zh) | 一种可以预防口腔溃疡的洁牙慕斯 | |
CN111298020B (zh) | 具有抗疲劳功效的中药组合物及其制备方法与应用 | |
CN108066224A (zh) | 一种安胃疡牙膏及其制备方法 | |
CN102846517B (zh) | 祛痱止痒的中药组合物及含该中药组合物的化妆品 | |
CN104306692A (zh) | 治疗牙龈肿痛的中药组合物及制法 | |
CN105125994A (zh) | 一种治疗口腔溃疡的中药 | |
CN107648494A (zh) | 一种治疗牙龈炎及口腔溃疡中药含漱液及其制备方法 | |
CN107812080A (zh) | 一种治疗口腔溃疡的泡腾片及其制备方法 | |
CN114209638B (zh) | 一种用于制备牙膏的复方苦丁茶中药组合物及复方苦丁茶中药牙膏 | |
CN109091598A (zh) | 一种口腔护理液及其加工工艺 | |
CN107854592A (zh) | 一种可快速消除疼痛感的口腔溃疡贴膜的制备方法 | |
CN114159536B (zh) | 药物组合物及其制备方法和应用 | |
CN108126021A (zh) | 一种治疗肾虚型牙齿松浮脱落的中药漱口水及其制备方法 | |
CN108309859A (zh) | 可食用儿童防龋齿漱口水及其制备方法 | |
CN104906352A (zh) | 一种治疗虚火上炎型小儿口疮的中药药液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |